AKAP12 and squamous cell lung carcinoma: Using the BEST database, we further investigated the possible correlation between AKAP12 expression and drug sensitivity of VEGF receptor inhibitors in OV, GBM, CRC, and lung squamous cell carcinoma (LUSC) patients.